CowdryR. W.GoodwinF. K. (1978) Amine neurotransmitter studies and psychiatric illness: toward more meaningful diagnostic concepts. In SpitzerR. L.KleinD. F. (eds.) Critical Issues in Psychiatric Diagnosis, Raven Press, New York, pp. 281–304.
2.
MurphyD. L.CampbellI. C.CostaJ. L. (1978) The brain serotonergic system in the affective disorders. Prog Neuropsychopharmacol, 2, 1–31.
3.
TraskmanL.AsbergM.BertilssonL.SjostrandL. (1981) Monoamine metabolites in CSF and suicidal behaviour. Arch. Gen. Psych., 38, 631–636.
4.
RossS. B.OgrenS. O.RenyiA. L. (1976) (Z)-dimethyl-amino-a-(4 bromophenyl)-1-(3-pyridyl) propene (H 102/09) a new selective inhibitor of the neuronal 5-hydroxytyptamine uptake. Acta Pharmacol Toxicol, 39, 152–166.
5.
MaasJ. W. (1978) Clinical implications of pharmacological differences among antidepressants. In LiptonM. A.di MascioA.KillanK. F. (eds.) Psychopharmacology: a Generation of Progress, Raven Press, New York, 1978.
6.
WaldmeirP. C.GreengrassP. M.BaumannP.MaitreL. (1976) Effects of Clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover. Post Graduate Medical Journal, 52 (Suppl, 3), 33–39.
